×

Eli Lilly’s Zepbound outperforms Novo Nordisk’s Wegovy for weight loss in trial

By Thomson Reuters May 11, 2025 | 5:19 PM
Persons with disabilities needing assistance with public inspection file content should contact our Support Desk here.